Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD

Authors not listed

Avid Radiopharmaceuticals · 2017

Abstract

This protocol is designed to serve as a pre-screening study for subjects who are potentially eligible for Alzheimer's Disease (AD) therapeutic trials that require tau imaging for inclusion by means of a flortaucipir F18 Positron Emission Tomography (PET) scan.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-14 MST

Cite this

APA
Anonymous. (2017). A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD. <em>Avid Radiopharmaceuticals</em>. https://clinicaltrials.gov/study/NCT03322462
Vancouver
Anonymous. A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD. Avid Radiopharmaceuticals. 2017.
BibTeX
@misc{anon2017AMulti, title = {A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD}, author = {Anonymous}, journal = {Avid Radiopharmaceuticals}, year = {2017}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings